Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old)
about
Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old)
description
clinical trial
@en
klinisch onderzoek
@nl
name
Safety and Immunogenicity of T ...... hi in Adults (18-40 Years Old)
@en
type
label
Safety and Immunogenicity of T ...... hi in Adults (18-40 Years Old)
@en
prefLabel
Safety and Immunogenicity of T ...... hi in Adults (18-40 Years Old)
@en
P1050
P1476
A Phase 2, Randomized, Observe ...... Subjects 18 to 40 Years of Age
@en
P17
P3098
NCT01193907
P580
2010-10-01T00:00:00Z
P582
2010-11-01T00:00:00Z